...
首页> 外文期刊>BMC Medical Imaging >Feasibility evaluation of micro-optical coherence tomography (μOCT) for rapid brain tumor type and grade discriminations: μOCT images versus pathology
【24h】

Feasibility evaluation of micro-optical coherence tomography (μOCT) for rapid brain tumor type and grade discriminations: μOCT images versus pathology

机译:用于快速脑肿瘤类型和等级鉴别的微光相干断层扫描(μCT)的可行性评价:μOC图像与病理学

获取原文
           

摘要

Precise identification, discrimination and assessment of central nervous system (CNS) tumors is of critical importance to brain neoplasm treatment. Due to the complexity and limited resolutions of the existing diagnostic tools, however, it is difficult to identify the tumors and their boundaries precisely in clinical practice, and thus, the conventional way of brain neoplasm treatment relies mainly on the experiences of neurosurgeons to make resection decisions in the surgery process. The purpose of this study is to explore the potential of Micro-optical coherence tomography (μOCT) as an intraoperative diagnostic imaging tool for identifying and discriminating glioma and meningioma with their microstructure imaging ex vivo, which thus may help neurosurgeons to perform precise surgery with low costs and reduced burdens. Fresh glioma and meningioma samples were resected from patients, and then slices of such samples were excised and imaged instantly ex vivo with a lab-built μOCT, which achieves a spatial resolution of ~?2.0?μm (μm). The acquired optical coherence tomography (OCT) images were pathologically evaluated and compared to their corresponding histology for both tumor type and tumor grade discriminations in different cases. By using the lab-built μOCT, both the cross-sectional and en face images of glioma and meningioma were acquired ex vivo. Based upon the morphology results, both the glioma and meningioma types as well as the glioma grades were assessed and discriminated. Comparisons between OCT imaging results and histology showed that typical tissue microstructures of glioma and meningioma could be clearly identified and confirmed the type and grade discriminations with satisfactory accuracy. μOCT could provide high-resolution three-dimensional (3D) imaging of the glioma and meningioma tissue microstructures rapidly ex vivo. μOCT imaging results could help discriminate both tumor types and grades, which illustrates the potential of μOCT as an intraoperative diagnostic imaging tool to help neurosurgeons perform their surgery precisely in tumor treatment process.
机译:对中枢神经系统(CNS)肿瘤的精确鉴定,歧视和评估对脑肿瘤治疗至关重要。然而,由于现有诊断工具的复杂性和有限的分辨率,难以在临床实践中识别肿瘤及其界限,因此脑肿瘤​​治疗的常规方式主要依赖于神经外科的经历手术过程中的决定。本研究的目的是探讨微光相干断层摄影(μOC)作为术中​​诊断成像工具的潜力,用于鉴定和鉴定胶质瘤和脑膜瘤的微观结构成像,因此可能有助于神经外部,以便低成本成本和负担减少。从患者中切除新鲜的胶质瘤和脑膜瘤样品,然后用实验室内部μCT切除这些样品的切片并立即造成〜Δ2.0?μm(μm)的空间分辨率。所获得的光学相干断层扫描(OCT)图像在病理学评价,并与其相应的组织学相比于不同病例中的肿瘤类型和肿瘤级鉴别。通过使用实验室内构建的μOCCT,获得了胶质瘤和脑膜瘤的横截面和en面部图像。基于形态结果,评估和歧视胶质瘤和脑膜瘤类型以及胶质瘤等级。 OCT成像结果和组织学之间的比较表明,可以清楚地识别胶质瘤和脑膜瘤的典型组织微观结构,并以满意的精度证实了类型和等级的鉴别。 μOC可以提供迅速地外胶质瘤和脑膜瘤组织微观结构的高分辨率三维(3D)成像。 μOT成像结果可以帮助区分肿瘤类型和等级,其说明μOC作为术中诊断成像工具的潜力,以帮助神经外科治疗精确地在肿瘤处理过程中进行手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号